Results 1 to 10 of about 59,823 (200)

Chlorpromazine overcomes temozolomide resistance in glioblastoma by inhibiting Cx43 and essential DNA repair pathways

Journal of Translational Medicine
Background In the fight against GBM, drug repurposing emerges as a viable and time-saving approach to explore new treatment options. Chlorpromazine, an old antipsychotic medication, has recently arisen as a promising candidate for repositioning in GBM ...
Paola Matarrese, Michele Signore, Barbara Ascione, Giulia Fanelli, Marco G. Paggi, Claudia Abbruzzese   +5 more
doaj   +1 more source

Application and advance of temozolomide in the treatment of pituitary adenomas

Chinese Journal of Contemporary Neurology and Neurosurgery, 2015
Pituitary adenoma is a common primary tumor in central nervons system. The aggressive pituitary adenomas show invasive characteristics with higher recurrence rate and worse prognosis, which normally need the comprehensive therapy of surgery ...
Yi-guang LIN, Xiao-min LIU
doaj  

Temozolomide reconsidered: Real-World evidence in resistant melanoma cases. [PDF]

Oncologist
Maselli-Schoueri JH, Martinez E, Lagos E, Campos EF, Saldanha EF, Muniz TP, Butler MO, Saibil SD.   +7 more
europepmc   +1 more source

Correction: Molecular subtypes and the (in vitro) response of glioblastoma to temozolomide. [PDF]

BJC Rep
Rancati S, Campolungo M, Duarte Dalmolin G, Lau P, Furia F, Coppe A, Landuzzi F, Vecchi M, Cavalli A, Gustincich S, Tirelli N.   +10 more
europepmc   +1 more source

Advancements in Glioblastoma Multiforme Treatment: A Comprehensive Systematic Review and Meta-Analysis. [PDF]

Brain Behav
Agboola K, Khafaji F, Chaurasia B, Qureshi K, Yangi K, Chavda V, Balak N.   +6 more
europepmc   +1 more source

Right Frontal Isocitrate Dehydrogenase (IDH)-Mutant WHO Grade 3 Oligodendroglioma Presenting With Morning Headache and Gait Imbalance. [PDF]

Cureus
Metwaly L.
europepmc   +1 more source

Cabozantinib and temozolomide in patients with advanced progressive neuroendocrine tumors: a phase 2 study. [PDF]

Nat Commun
Cives M, Della Vittoria Scarpati G, Clemente O, Lauricella E, Bracigliano A, Badalamenti G, Delrio P, Cannella L, Picone C, Ragno A, Chaoul N, Della Monica R, Di Mauro A, Pizzolorusso A, Sorino J, Buonaiuto M, Ingravallo G, Picozzi F, Pignataro P, Ferrara G, Porta C, Tafuto S.   +21 more
europepmc   +1 more source

Anlotinib combined with temozolomide for brain metastases in small cell lung cancer with early recurrence after whole-brain radiotherapy: a case report. [PDF]

Front Med (Lausanne)
Jiang B, Wang X, Zhang T, Liu Q, Zhang X, Zhang B.   +5 more
europepmc   +1 more source

Anlotinib-temozolomide combination achieves durable response in multimodal-resistant primary breast angiosarcoma with skull base metastasis and dural involvement: a case report. [PDF]

Front Oncol
Song S, Chen W, Li X, Zhang Y, Wang Y.
europepmc   +1 more source

Final Subcortical Motor Mapping Threshold and Overall Survival After Motor-Eloquent Glioblastoma Resection: Exploratory Analysis of Residual Fluorescence at the Motor Boundary. [PDF]

Cancers (Basel)
Krupa P, Kotek F, Bartos M, Vachek M, Krupova M, Paulikova S, Kasparova P, Cesak T.   +7 more
europepmc   +1 more source